Mesoblast Limited (Mesoblast) is engaged in the principal activity of developing bio-therapeutics based on its cell-based and protein technologies. Mesoblast’s cell-based core technologies include its immunoselected Mesenchymal Precursor Cells (MPCs), culture-expanded Mesenchymal Stem Cells (MSCs), Dental Pulp Stem Cells (DPSCs), and expanded Hematopoietic Stem Cells (HSCs).
Please wait processing your request...
US
AU
UK
CA
NZ